This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: London School of Hygiene and Tropical Medicine. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: Lisa Dawson: Innovator in Therapeutic Solutions
Introduction
Lisa Dawson is a prominent inventor based in London, GB. She has made significant contributions to the field of therapeutics, particularly in the treatment of infections. With a total of two patents to her name, her work is focused on innovative solutions that address critical health challenges.
Latest Patents
Dawson's latest patents include a therapeutic for treating Clostridium difficile infection. This invention relates to the use of deoxyribonuclease in various applications, including pharmaceutical and veterinary compositions. The patent outlines methods for treating mammals suspected of being infected, as well as cleaning and sterilizing products that incorporate deoxyribonuclease. These advancements highlight her commitment to improving health outcomes through innovative therapeutic approaches.
Career Highlights
Lisa Dawson is affiliated with the London School of Hygiene and Tropical Medicine, where she contributes to research and development in the field of infectious diseases. Her work is characterized by a strong focus on practical applications that can lead to significant improvements in public health.
Collaborations
Dawson collaborates with Brendan Wren, a fellow researcher, to further enhance the impact of their work in the field of therapeutics. Their partnership exemplifies the importance of collaboration in driving innovation and addressing complex health issues.
Conclusion
Lisa Dawson's contributions to the field of therapeutics, particularly through her innovative patents, demonstrate her dedication to advancing medical science. Her work not only addresses critical health challenges but also paves the way for future innovations in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
